Thermo Fisher Scientific
TMO on NYSE. Thermo Fisher Scientific sells laboratory equipment, chemicals, and services to scientists and medical laboratories. Market value $250.2bn.
Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.
Should I look at this?
Good business, but not cheap right now
Why it could be worth it
See cheaper Health care stocks on the list
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $2.92 of spare cash in the past 12 months. A savings account pays about $4.
You pay 35.4 years of operating profit for the business. The average large US company costs around 18.
Each dollar kept in the business earns 8 cents a year. Above 10 is good.
Quality score: 90 of 100. Price score: 31 of 100. Our list needs 70 on quality and 60 on price.
$676.76 a share, 55% above its 1-year low
Over the past year the price has ranged from $435.27 to $683.63.
Dividend: 0.3% a year
Paid every year for at least 5 years
Prices from Monday’s close (5 October).
Five years of cash, in billions
| Revenue | |||||
| Revenue | $39.2bn | $44.9bn | $42.9bn | $42.9bn | $44.6bn |
| Operating margin | |||||
| Operating margin | 25.6% | 18.7% | 16.0% | 17.1% | 17.4% |
| Debt to equity | |||||
| Debt to equity | 0.85 | 0.78 | 0.75 | 0.63 | 0.74 |
| Shares outstanding | |||||
| Shares outstanding | 0.39bn | 0.39bn | 0.38bn | 0.38bn | 0.37bn |
Health checks
- Free cash flow positive5 of 5 years
- Accounting looks honest (Beneish)Not enough data
- Financial strength (Piotroski)5 of 7 checks we could run
- Profit backed by cash (accruals)Yes
- Debt0.74× equity
- Revenue growth, five yearsSlow, 6.7% a year
- Buying back its own sharesYes, 6% fewer since 2021
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $12 billion last quarter, up 10% on a year ago.
- Profit: $1.7 billion, up 7% on a year ago.
- It keeps 18 cents of each $1 of sales as operating profit, up from 17 cents a year earlier.
- Spare cash over the past 12 months: $7.3 billion, up from $6.2 billion.
- 2% fewer shares than a year ago. Each share owns a bit more of the company.
- Debt is $38.5 billion more than cash, up from $30.7 billion a year ago.
- Sales grew on a year ago in each of the last 4 quarters.
| Quarter to | Amount |
|---|---|
| September 2024 | $10.6bn |
| December 2024 | $11.4bn |
| March 2025 | $10.4bn |
| June 2025 | $10.9bn |
| September 2025 | $11.1bn |
| December 2025 | $12.2bn |
| March 2026 | $11.0bn |
| June 2026 | $12.0bn |
| Quarter to | Amount |
|---|---|
| September 2024 | $1.6bn |
| December 2024 | $1.8bn |
| March 2025 | $1.5bn |
| June 2025 | $1.6bn |
| September 2025 | $1.6bn |
| December 2025 | $2.0bn |
| March 2026 | $1.7bn |
| June 2026 | $1.7bn |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- 21 October 2026
- Last annual report (10-K)
- 26 February 2026
- Next quarterly (estimated, 10-Q)
- 30 October 2026
Who owns it
31 long-term investors we follow own it, down from 32 last quarter. 2,616 funds in all.
- Century ManagementArnold Van Den Berg
- Value
- $7m
- Share of fund
- 1.5%
- Beutel GoodmanBeutel Goodman team
- Value
- $1m
- Share of fund
- <0.1%
- Mairs & PowerAndy Adams
- Value
- $622,188
- Share of fund
- <0.1%
- LSV Asset ManagementJosef Lakonishok
- Value
- $451,000
- Share of fund
- <0.1%
- Horizon KineticsMurray Stahl
- Value
- $219,596
- Share of fund
- <0.1%
Sold out this quarter
Largest holders overall
- BlackRock$15.5bn
- Vanguard Capital Management$12.2bn
- State Street$8.4bn
- FMR$7.1bnAdded
- Morgan Stanley$5.4bn
- JPMorgan Chase$4.3bnAdded
- Geode Capital Management$4.2bn
- Franklin Resources$3.6bnAdded
- Vanguard Portfolio Management$3.1bn
- Capital World Investors$3.1bnCut
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
1 investor owns more than 5%.
- Vanguard Capital ManagementPassive investor7.5%Since 31 March 2026
- The Vanguard GroupPassive investorSold down below 5%Since 13 March 2026
| Holder | Stake | Since | |
|---|---|---|---|
Vanguard Capital Management Passive investor | 7.5% | 31 March 2026 | |
The Vanguard Group Passive investor | Sold down below 5% | 13 March 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought shares on the open market in the last 12 months. 7 sold $158m, $90m of it under preset trading plans.
- Pettiti GianlucaPresident & COOSoldunder a preset trading plan
- Date
- 31 August 2026
- Shares
- 4,133
- Price
- $614.38
- Value
- $3m
- CASPER MARC NChairman & CEO, DirectorSoldunder a preset trading plan
- Date
- 24 August 2026
- Shares
- 275
- Price
- $627.05
- Value
- $172,439
- CASPER MARC NChairman & CEO, DirectorSoldunder a preset trading plan
- Date
- 21 August 2026
- Shares
- 10,000
- Price
- $626.92
- Value
- $6m
- CASPER MARC NChairman & CEO, DirectorSoldunder a preset trading plan
- Date
- 20 August 2026
- Shares
- 10,000
- Price
- $629.27
- Value
- $6m
- Britt Lisa P.Sr. VP and Chief HR OfficerSold
- Date
- 19 August 2026
- Shares
- 11,440
- Price
- $613.12
- Value
- $7m
- Shafer Michael DExecutive Vice PresidentSoldunder a preset trading plan
- Date
- 11 August 2026
- Shares
- 25,500
- Price
- $600.00
- Value
- $15m
- Holmes Joseph R.VP & Chief Accounting OfficerSold
- Date
- 7 August 2026
- Shares
- 420
- Price
- $584.81
- Value
- $245,620
- CASPER MARC NChairman & CEO, DirectorSoldunder a preset trading plan
- Date
- 7 August 2026
- Shares
- 4,883
- Price
- $586.12
- Value
- $3m
- CASPER MARC NChairman & CEO, DirectorSoldunder a preset trading plan
- Date
- 6 August 2026
- Shares
- 15,000
- Price
- $574.46
- Value
- $9m
- Britt Lisa P.Sr. VP and Chief HR OfficerSold
- Date
- 6 August 2026
- Shares
- 5,850
- Price
- $580.00
- Value
- $3m
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 31 August 2026 | Pettiti Gianluca President & COO | Sold under a preset trading plan | 4,133 | $614.38 | $3m |
| 24 August 2026 | CASPER MARC N Chairman & CEO, Director | Sold under a preset trading plan | 275 | $627.05 | $172,439 |
| 21 August 2026 | CASPER MARC N Chairman & CEO, Director | Sold under a preset trading plan | 10,000 | $626.92 | $6m |
| 20 August 2026 | CASPER MARC N Chairman & CEO, Director | Sold under a preset trading plan | 10,000 | $629.27 | $6m |
| 19 August 2026 | Britt Lisa P. Sr. VP and Chief HR Officer | Sold | 11,440 | $613.12 | $7m |
| 11 August 2026 | Shafer Michael D Executive Vice President | Sold under a preset trading plan | 25,500 | $600.00 | $15m |
| 7 August 2026 | Holmes Joseph R. VP & Chief Accounting Officer | Sold | 420 | $584.81 | $245,620 |
| 7 August 2026 | CASPER MARC N Chairman & CEO, Director | Sold under a preset trading plan | 4,883 | $586.12 | $3m |
| 6 August 2026 | CASPER MARC N Chairman & CEO, Director | Sold under a preset trading plan | 15,000 | $574.46 | $9m |
| 6 August 2026 | Britt Lisa P. Sr. VP and Chief HR Officer | Sold | 5,850 | $580.00 | $3m |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
What could go wrong
- It isn't cheap on profits: 35.4× operating profit.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.